What is Luminare?
Luminare operates at the intersection of clinical informatics and hospital administration, providing a sophisticated platform designed to mitigate sepsis mortality and optimize patient outcomes. The company's core value proposition lies in its patented patient phenotyping algorithm, which integrates directly into existing Electronic Health Record (EHR) systems. This seamless technical architecture allows healthcare providers to identify critical patient risks in real-time, thereby reducing ICU length of stay and enhancing overall safety protocols. By focusing on high-impact clinical workflows, Luminare enables healthcare organizations to not only improve patient care standards but also realize significant gains in operational revenue and resource allocation efficiency.
How much funding has Luminare raised?
Luminare has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Luminare
PPP
Public-Private Partnership
What's next for Luminare?
With the infusion of this late-stage capital, Luminare is poised to scale its market presence and deepen its integration within the broader healthcare ecosystem. The strategic roadmap likely involves expanding the deployment of its phenotyping technology across a wider network of hospital systems, further refining its predictive capabilities, and potentially exploring new clinical applications for its core algorithm. As the company transitions into this growth phase, the focus will remain on demonstrating measurable clinical ROI to hospital stakeholders, ensuring that their technological solutions remain indispensable in the modern, data-driven medical environment.
See full Luminare company page
